Eurofins Agro Testing Supports CO2 Reduction With Soil Carbon Check Offering
05 December 2022 - 5:15PM
Business Wire
Regulatory News:
Eurofins (Paris:ERF):
To mark World Soil Day (December 5th), Eurofins Agro Testing
announces the launch of Soil Carbon Check as part of Soil Health
Solutions, a new suite of testing solutions that will support the
agricultural sector to transition to more sustainable farming
practices. The Soil Carbon Check test will provide insights into
the levels of carbon storage in fields, which supports the
reduction of CO2 in the atmosphere. Through targeted soil
management, farmers and growers can sequester increased levels of
carbon and contribute to climate protection. Data garnered through
the Soil Carbon Check test reports can be used to support
sustainability claims and carbon credits, as proof of sustainable
farming and as credentials for other partners in the agri-food
chain.
The '4 per 1,000' initiative launched at the UN Climate Change
Conference in Paris in 2015 (COP21) aims to boost carbon storage in
agricultural soils by 0.4% each year to help mitigate climate
change and increase food security. The amount of carbon that is
stored in soil is as much as three times the amount of carbon
sequestered by above-ground biomass (trees or other plants and
crops). Increasing the amount of carbon stored in soil will
contribute to the reduction of global warming; the more CO2 stored
in soil as organic carbon, the less CO2 that is released into the
atmosphere.
Soil Carbon Check provides customers with information on how
much carbon is sequestered in their soil, how stable their soil
carbon is and how it can be improved, and tracks how the carbon
content of soil changes over time. In addition to Soil Carbon
Check, the suite of tests offered by Soil Health Solutions provide
insights into physical soil health (supporting the efficient use of
water), potential contaminants in soil, biological soil health (to
determine the biodiversity status of soil and effective actions to
regenerate it) and chemical soil health (to prevent yield gaps and
improve food quality). Further information is available here.
Notes to Editors:
For more information, please visit www.eurofins.com or
contact:
Investor Relations Eurofins Scientific SE Phone: +32 2 766 1620
E-mail: ir@eurofins.com
About Eurofins – the global leader in bio-analysis
Eurofins is Testing for Life. Eurofins is the global leader in
food, environment, pharmaceutical and cosmetic product testing, and
in discovery pharmacology, forensics, advanced material sciences
and agroscience Contract Research services. Eurofins is also a
market leader in certain testing and laboratory services for
genomics, and in the support of clinical studies, as well as in
BioPharma Contract Development and Manufacturing. The Group also
has a rapidly developing presence in highly specialised and
molecular clinical diagnostic testing and in-vitro diagnostic
products.
With over 61,000 staff across a decentralised and
entrepreneurial network of 940 laboratories in 59 countries,
Eurofins offers a portfolio of over 200,000 analytical methods to
evaluate the safety, identity, composition, authenticity, origin,
traceability and purity of a wide range of products, as well as
providing innovative clinical diagnostic testing services and
in-vitro diagnostic products.
The Group’s objective is to provide its customers with
high-quality services, innovative solutions and accurate results on
time. Eurofins is ideally positioned to support its clients’
increasingly stringent quality and safety standards and the
increasing demands of regulatory authorities as well as the
requirements of healthcare practitioners around the world.
In 2020 and 2021, Eurofins reacted quickly to meet the global
challenge of COVID-19, by creating the capacity to help over 20
million patients monthly who may have been impacted by the pandemic
with our testing products and our services and directly supporting
healthcare professionals working on the front line to fight the
virus. The Group has established widespread PCR testing
capabilities and has carried out over 40 million tests in its own
laboratories, is supporting the development of a number of vaccines
and has established its SAFER@WORK™ testing, monitoring and
consulting programmes to help ensure safer environments, travel and
events during COVID-19.
Eurofins has grown very strongly since its inception and its
strategy is to continue expanding its technology portfolio and its
geographic reach. Through R&D and acquisitions, the Group draws
on the latest developments in the field of biotechnology and
analytical chemistry to offer its clients unique analytical
solutions.
Shares in Eurofins Scientific are listed on the Euronext Paris
Stock Exchange (ISIN FR0014000MR3, Reuters EUFI.PA, Bloomberg ERF
FP).
Until it has been lawfully made public widely by Eurofins
through approved distribution channels, this document contains
inside information for the purpose of Regulation (EU) 596/2014 of
the European Parliament and of the Council of 16 April 2014 on
market abuse, as amended.
Important disclaimer:
This press release contains forward-looking statements and
estimates that involve risks and uncertainties. The forward-looking
statements and estimates contained herein represent the judgment of
Eurofins Scientific’s management as of the date of this release.
These forward-looking statements are not guarantees for future
performance, and the forward-looking events discussed in this
release may not occur. Eurofins Scientific disclaims any intent or
obligation to update any of these forward-looking statements and
estimates. All statements and estimates are made based on the
information available to the Company’s management as of the date of
publication, but no guarantees can be made as to their completeness
or validity.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221204005015/en/
Investor Relations Eurofins Scientific SE Phone: +32 2 766 1620
E-mail: ir@eurofins.com
Enerplus (NYSE:ERF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Enerplus (NYSE:ERF)
Historical Stock Chart
From Jul 2023 to Jul 2024